| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2019/11/16 | 07 : 15 | Dow Jones News | Johnson & Johnson's Oklahoma Opioid Penalty Reduced to $465 Million | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/11/08 | 23 : 44 | Business Wire | Teva Announces $1.5 Billion Debt Tender Offers | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/11/08 | 23 : 43 | Business Wire | Teva Announces Launch of $1,500,000,000 Offering of Senior Notes | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/11/08 | 06 : 37 | Dow Jones News | High Debt, Potential Litigation Costs Face New Teva CFO | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/11/07 | 21 : 15 | Business Wire | Teva & Celltrion Announce the Availability of TRUXIMA® (rituximab-abbs) Injection, the First Biosimilar to Rituxan® (rituxi... | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/11/07 | 21 : 05 | Business Wire | Teva Announces Appointment of New Chief Financial Officer | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/11/07 | 21 : 00 | Business Wire | Teva Reports Third Quarter 2019 Financial Results | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/11/02 | 07 : 00 | Business Wire | Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 (Updated Dial-i... | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/31 | 22 : 00 | PR Newswire (Canada) | Teva Canada annonce le lancement des capsules [Pr]Teva-Fingolimod, une version générique bioéquivalente de [Pr]Gilenya®, ... | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/31 | 21 : 54 | PR Newswire (Canada) | Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the tr... | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/24 | 21 : 00 | Business Wire | Teva to Present New Analyses of Fremanezumab and Country-Specific Burden of Migraine at 24th World Congress of Neurology | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/22 | 16 : 02 | Dow Jones News | Opioid Deal Lifts Odds for Broader Accord -- WSJ | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/22 | 05 : 25 | Dow Jones News | Opioid Deal Could Open Door to Bigger Settlement -- Update | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/22 | 03 : 43 | Dow Jones News | Teva to Donate Buprenorphine Naloxone Valued at About $23 Billion in Opioid-Related Settlement | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/22 | 02 : 53 | Business Wire | Teva Settles Track 1 Opioid Cases and Reaches Agreement on Framework to Settle Remaining Litigation | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/21 | 23 : 34 | Dow Jones News | Four Drug Companies Reach Last-Minute Settlement in Opioid Litigation -- 3rd Update | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/21 | 21 : 57 | Dow Jones News | Four Drug Companies Reach Last-Minute Settlement in Opioid Litigation -- 2nd Update | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/21 | 21 : 21 | Dow Jones News | Four Drug Companies Reach Last-Minute Settlement in Opioid Litigation--Update | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/19 | 11 : 48 | Dow Jones News | More Money Demanded in Opioid Settlement Talks -- Update | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/19 | 08 : 57 | Dow Jones News | More Money Demanded in Opioid Settlement Talks | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/18 | 16 : 02 | Dow Jones News | Bellwether Opioid Deal Talks Ramp Up -- WSJ | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/18 | 07 : 15 | Dow Jones News | Talks to Settle Opioid Lawsuits Intensify | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/08 | 06 : 00 | Business Wire | Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/02 | 21 : 30 | Business Wire | Teva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at Psych Congress 2019 | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/02 | 21 : 00 | Business Wire | Teva Announces Leadership Change in its Global Operations Group | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/10/01 | 06 : 41 | Dow Jones News | Drugmakers Look to Use Purdue Pharma's Bankruptcy to Settle Opioid Suits | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/09/14 | 02 : 52 | Dow Jones News | Correction to Opioid Reckoning Hits Money Managers | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/09/13 | 21 : 29 | Dow Jones News | Opioid Reckoning Hits Money Managers | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/09/13 | 18 : 00 | PR Newswire (US) | INTERCURE: CANNDOC signs strategic distribution agreement with S.L.E. of TEVA Pharmaceuticals | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/09/13 | 18 : 00 | PR Newswire (US) | INTERCURE: CANNDOC signs strategic distribution agreement with S.L.E. of TEVA Pharmaceuticals | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |